In multivariable analysis, this effect almost completely disappeared, although risk estimates were still marginally significant for users of ACEIs (HR 1.10, 95% CI 1.03–1.17), ARBs (HR 1.12, 95% CI 1.05–1.20) and CCBs (HR 1.11, 95% CI 1.03–1.21).
← all excerpts
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
1
—
—